https://www.selleckchem.com/pr....oducts/Temsirolimus.
Increasing age is a known negative prognostic factor for glioblastoma. However, a multifactorial approach is necessary to achieve optimal neuro-oncological treatment. It remains unclear to what extent frailty, comorbidity burden, and obesity might exert influence on survival in geriatric glioblastoma patients. We have therefore reviewed our institutional database to assess the prognostic value of these factors in elderly glioblastoma patients. Between 2012 and 2018, patients aged ≥ 65years with newly diagnosed glioblastoma were inc
Like
Comment
Share
